title: An approach to management of keloids.
abstract: Keloids present a major therapeutic dilemma for the surgeon because of frequent recurrences. We use a new protocol for management of large primary or recalcitrant keloids. The technique employs carbon dioxide laser resection of the keloid and then allows the open wound bed to heal by secondary intention. The open wound is treated as though it were a third-degree skin burn. The wounds invariably orient their long axis parallel to the relaxed skin tension lines. No keloid has ever been noted to recur before epithelial migration is complete. Careful follow-up detects early recurrences that are then treated with injection consisting of 40 mg/mL of triamcinolone acetonide (Kenalog), 150 mg of hyaluronidase (Wydase), and 2% lidocaine via a dermajet. Thirty-seven patients were treated with this protocol and have been followed up for at least 2 years. A control rate of 84% has been achieved with compliant patients.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Louisiana State University Medical Center, Shreveport 71130.
authors.forename: F J
authors.initials: FJ
authors.lastname: Stucker
authors.forename: G Y
authors.initials: GY
authors.lastname: Shaw
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage; D007267:Injections; D007627:Keloid / Q000188:drug therapy / Q000601:surgery*; D053685:Laser Therapy / Q000295:instrumentation / Q000379:methods*; D008297:Male; D011182:Postoperative Care; D012008:Recurrence; D014222:Triamcinolone Acetonide / Q000008:administration & dosage
chemical_list: D006821:Hyaluronoglucosaminidase; D014222:Triamcinolone Acetonide